ArticleFoods (Basel, Switzerland)2026
Pigskin Collagen-Derived Antifreeze Peptides as Clean-Label Cryoprotectants: Inhibition of Ice Recrystallization and Suppression of Oxidative Deterioration in Heme-Rich Pork Sausages.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interaction and Flavor Metabolic Function of Microbiota During Fermentation of Pigskin Through Bioaugmentation withMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Frozen red meat products face dual challenges: structural damage from ice recrystallization and subsequent oxidative deterioration driven by endogenous pro-oxidants in heme-rich matrices. This study investigated the efficacy of pigskin collagen-derived antifreeze peptides (APPs) as clean-label cryoprotectants in pork sausages. In vitro characterization confirmed distinct thermal hysteresis (0.51 °C) and potent ice recrystallization inhibition. In the sausage system, 6% APPs overcame ionic screening effects, reducing thawing loss to 4.87% (vs. 7.51% in control) and cooking loss to 14.59%, significantly outperforming commercial phosphates in moisture retention. Low-field NMR revealed that APPs stabilized the actomyosin hydration shell, maintaining the immobilized water proportion (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.